These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 33006053)
1. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development. Calina D; Sarkar C; Arsene AL; Salehi B; Docea AO; Mondal M; Islam MT; Zali A; Sharifi-Rad J Immunol Res; 2020 Dec; 68(6):315-324. PubMed ID: 33006053 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 immunogenicity at the crossroads. Karamloo F; König R Allergy; 2020 Jul; 75(7):1822-1824. PubMed ID: 32401346 [No Abstract] [Full Text] [Related]
3. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development. Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK Front Immunol; 2020; 11():1880. PubMed ID: 32973779 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates. Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177 [TBL] [Abstract][Full Text] [Related]
5. Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2. Konwarh R Front Immunol; 2020; 11():1531. PubMed ID: 32655584 [No Abstract] [Full Text] [Related]
6. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies. Papageorgiou AC; Mohsin I Cells; 2020 Oct; 9(11):. PubMed ID: 33105869 [TBL] [Abstract][Full Text] [Related]
7. Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection. Qi X; Ke B; Feng Q; Yang D; Lian Q; Li Z; Lu L; Ke C; Liu Z; Liao G Chem Commun (Camb); 2020 Aug; 56(61):8683-8686. PubMed ID: 32613971 [TBL] [Abstract][Full Text] [Related]
8. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2. Yi C; Yi Y; Li J Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253 [No Abstract] [Full Text] [Related]
9. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Zhang C; Zhou C; Shi L; Liu G Hum Vaccin Immunother; 2020 Oct; 16(10):2366-2369. PubMed ID: 32961082 [TBL] [Abstract][Full Text] [Related]
10. A spike with which to beat COVID-19? Alam N; Higgins MK Nat Rev Microbiol; 2020 Aug; 18(8):414. PubMed ID: 32415242 [TBL] [Abstract][Full Text] [Related]
11. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation. Seydoux E; Homad LJ; MacCamy AJ; Parks KR; Hurlburt NK; Jennewein MF; Akins NR; Stuart AB; Wan YH; Feng J; Whaley RE; Singh S; Boeckh M; Cohen KW; McElrath MJ; Englund JA; Chu HY; Pancera M; McGuire AT; Stamatatos L Immunity; 2020 Jul; 53(1):98-105.e5. PubMed ID: 32561270 [TBL] [Abstract][Full Text] [Related]
12. Coronavirus vaccines get a biotech boost. Dance A Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847 [No Abstract] [Full Text] [Related]
13. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802 [TBL] [Abstract][Full Text] [Related]
14. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Samrat SK; Tharappel AM; Li Z; Li H Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196 [TBL] [Abstract][Full Text] [Related]
15. Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice. Liu X; Drelich A; Li W; Chen C; Sun Z; Shi M; Adams C; Mellors JW; Tseng CT; Dimitrov DS Vaccine; 2020 Oct; 38(46):7205-7212. PubMed ID: 33010978 [TBL] [Abstract][Full Text] [Related]
16. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding. Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccine: A comprehensive status report. Kaur SP; Gupta V Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805 [TBL] [Abstract][Full Text] [Related]